Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GK.12NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HK.14NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HK.14NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.14NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XDCNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XDCNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDCNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.15.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.15.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.15.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JR.1.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JR.1.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JR.1.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JD.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JD.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JD.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JG.3.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JG.3.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JG.3.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KE.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KE.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KE.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HV.1.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HV.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HV.1.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.86.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.86.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.86.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HK.8NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HK.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.8NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HK.26.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HK.26.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.26.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XCPNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XCPNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XCPNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.1.8NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.1.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.1.8NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EG.6.1.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EG.6.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.6.1.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EG.5.1.12NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EG.5.1.12NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.5.1.12NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JF.1.1.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JF.1.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JF.1.1.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HK.11NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used